Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
06/1997
06/25/1997CN1152874A Copolymer-1 improvements in compositions of copolymers
06/25/1997CN1152866A Soap composition
06/25/1997CN1152468A Slow releasing composition
06/24/1997US5641805 Topical ophthalmic formulations for treating allergic eye diseases
06/24/1997US5641517 Composition comprising fertilized shell eggs
06/24/1997US5641477 Consists of hydrogenated starch hydrolyzate and/or sugar
06/24/1997US5641471 Method for preparing 213 Bi for therapeutic use
06/18/1997EP0778766A1 Topically-effective compositions
06/18/1997CN1035180C Prep. of Macrolide antibiotics
06/17/1997US5639463 Clear cosmetic stick composition
06/12/1997WO1997020815A1 Compounds
06/12/1997WO1997020564A1 Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)
06/11/1997EP0778025A1 Use of 8,9-dehydroestrone for the manufacture of a medicament for the treatment of diseases caused by free radicals
06/11/1997EP0654991B1 Inhalation powder containing antistatic agent
06/11/1997CN1151699A Health compsn.
06/11/1997CN1151697A Anti-hiv triple combination
06/11/1997CN1151696A 抗菌剂 Antibacterial agents
06/10/1997US5637572 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis
06/05/1997WO1997019668A2 Toothpaste and mouthwash in tablets
06/05/1997WO1996039113A3 Oral administration of pneumococcal antigens
06/05/1997CA2191835A1 Use of 8,9-dehydroestrone as an antioxidant
06/04/1997EP0776219A2 Compositions
06/04/1997CN1151164A Sterol derivatives used for regulation of meiosis
06/03/1997USRE35524 Antitumor agents
06/03/1997US5635187 Adding phytogenic compounds to storage solution to increase organ preservation for transplantation
06/03/1997US5635186 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
06/03/1997US5635185 Extracts of Piliostigma thonningii, the use thereof and formulations containing them
06/03/1997US5635164 Stick composition with sodium chloride and stearyl alcohol
06/03/1997CA2143204C Use of dideoxy nucleoside analogues in the treatment of viral infections
06/03/1997CA2098199C Psyllium and cholestyramine compositions with improved palatability
06/03/1997CA2067888C Cosmetic composition
05/1997
05/29/1997WO1997018841A1 Non-invasive localization of a light-emitting conjugate in a mammal
05/29/1997WO1997018833A1 Methods of increasing lean tissue mass using ob protein compositions
05/29/1997CA2358862A1 Methods of increasing lean tissue mass using ob protein compositions
05/29/1997CA2236163A1 Methods of increasing lean tissue mass using ob protein compositions
05/28/1997EP0775482A2 Cosmetic compositions containing tricholine citrate
05/28/1997EP0774969A1 Hiv protease inhibitor combination
05/28/1997EP0671918B1 Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections
05/27/1997US5633241 Administering as antileukemia agent
05/21/1997CN1150435A Process for removing bile salt from patient and alkylated compositions therefor
05/20/1997US5631245 Di-beta-glycopyranosylamine from glucose and nitrogen base
05/20/1997US5631241 Wound healing agents of high molecular weight for eyes as antiinflammatory agents
05/20/1997US5630999 Oral composition containing anionic surfactants having reduced adverse reaction to oral tissue
05/15/1997WO1997017343A1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands
05/15/1997CA2236678A1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands
05/14/1997EP0772447A1 Chinese herbs extract
05/14/1997EP0772446A1 Anti-adhesion agent
05/14/1997EP0772444A1 Use of the enantiomers of oxazophosphorines, e.g. ifosfamide, in anti-tumour therapy, for reducing side-effects
05/14/1997CN1149831A Controlled-release dosage forms of azithromycin
05/14/1997CN1149830A Pyridylbisphosphonates for use as therapeutical agent
05/13/1997US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor
05/13/1997US5629303 Controlled release systems and low dose androgens
05/09/1997WO1997016439A1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
05/09/1997WO1997016197A1 Extracts of shark cartilage
05/09/1997WO1997016193A1 Pharmaceutical composition for treating osteoporosis
05/09/1997WO1997016162A1 Underarm compositions
05/09/1997WO1997016161A1 Underarm compositions
05/07/1997EP0771789A1 1 alpha, 26-dihydroxy-D-homo-vitamin D3
05/07/1997EP0771202A1 USE OF (S)-ADENOSYL-L-METHIONINE (SAMe) AND ITS PHYSIOLOGICALLY COMPATIBLE SALTS FOR TREATING REPERFUSION DAMAGE TRIGGERED BY TEMPORARY FOCAL ISCHAEMIA
05/07/1997EP0771188A2 Soap composition
05/07/1997EP0621870B1 A human kunitz-type protease inhibitor variant
05/07/1997EP0602050B1 Method of stimulating immune response
05/07/1997CN1149251A Combined two-part reducing agent/humectant shaving system for inproved shaving comfort
05/07/1997CN1149250A Improved anti-dandruff shampoo
05/06/1997US5627186 Treatment of htlv or aids with 4-amino-1-(2-hydroxymethyl oxathiolan-5-yl)-1h-pyrimidin-2-one with 3'-azido-3'-deoxy thymidine
05/06/1997US5626852 Composition containing body activated fragrance for contacting the skin and method of use
05/02/1997EP0769965A1 Aqueous risperidone formulations
05/01/1997WO1997015280A1 Use of at least one no synthase inhibitor for treating sensitive skin
05/01/1997CA2188634A1 1ó,26 dihydroxy-d-homo-vitamin d3
04/1997
04/30/1997CN1148855A Novel spiro [indole-pyrrolidine]derivatives as melatoninergic agonists, method for preparing same and use thereof as drug
04/30/1997CN1148849A Process for preparing anhydrous and hydrate forms of antihistaminic pipeeridine derivatives, polymorphs and spseudormophs thereof
04/30/1997CN1148596A Noval crystal type anhydrous 7-([1 alpha, 5 alpha, 6 alpha]-6-amino-3-azabicyclo[3,1,0]hexyl-3-group)-6-fluorine-1-(2,4-difluorophenyl
04/29/1997US5624672 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
04/24/1997WO1997014686A1 Pharmaceutically active quinazoline compounds
04/24/1997WO1997014397A1 A depilatory composition with improved rinsing properties
04/24/1997CA2235304A1 Pharmaceutically active quinazoline compounds
04/23/1997EP0768884A1 Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin
04/23/1997EP0768881A2 Anti-hiv triple combination
04/23/1997EP0768872A1 New oral pharmaceutical formulation containing magnesium salt of omeprazole
04/23/1997CN1148344A New oral pharmaceutical dosage form
04/23/1997CN1147961A Stable liquid composition containing urate oxidase and lyophilized composition for its prepn.
04/23/1997CN1034631C Process for producing new agent having antiphlogistic activity
04/22/1997US5622952 Glycine receptor antagonists and the use thereof
04/17/1997WO1997013495A1 Antimicrobial compositions containing a c3-c6 alcohol
04/17/1997WO1997013492A2 Strengthening agent
04/17/1997CA2232640A1 Antimicrobial compositions containing a c3-c6 alcohol
04/16/1997EP0768089A1 Health composition
04/16/1997EP0768085A1 Antibacterial agent
04/16/1997EP0767798A1 Sterol derivatives used for regulation of meiosis
04/16/1997EP0767664A2 Combination therapy for hiv infection
04/16/1997EP0502180B1 Enzymatic synthesis of oligonucleotides
04/16/1997CN1147765A Remedy for pulmonary heart
04/16/1997CN1147520A 11-(substituted phenyl)-estra-4,9-diene derivatives
04/16/1997CN1147516A Bioavailable crystalline form of cefuroxime axetil
04/16/1997CN1034553C Avirulent microbes and uses therefor
04/15/1997US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain
04/15/1997US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases
04/15/1997US5620979 Treating neuronal loss associated with stroke, ischemia, central nervous system trauma, hypoglycemia or surgery
04/15/1997US5620885 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
04/15/1997US5620697 Mixing biodegradable polymer and solid drug, exposure to ultrasonic frequency vibrations for melting, then cooling yields sustained release composite for drug delivery